Código QR (código de barras bidimensional)

Combining SARS-CoV-2 Proofreading Exonuclease and RNA-Dependent RNA Polymerase Inhibitors as a Strategy to Combat COVID-19: A High-Throughput in silico Screening

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of people worldwide. Currently, many clinical trials in search of effective COVID-19 drugs are underway. Viral RNA-dependent RNA polymerase (RdRp) remains the target of choice for prophylactic or curative treatment of...

ver descrição completa

Na minha lista:
Principais autores: Shradha Khater, Pawan Kumar, Nandini Dasgupta, Gautam Das, Shashikant Ray, Amresh Prakash
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021-07-01
coleção:Frontiers in Microbiology
Assuntos:
SARS-CoV-2
drug repurposing
exonuclease inhibitor
nucleoside analog
molecular docking and MD simulation
combinatorial therapy
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fmicb.2021.647693/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados